The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I re-listened to the podcast, I am sure Cathal said in the coming week (WC 8th of June) they will be signing a contract with 1 of the top 3 pharmas, and by the end of the month 3 of the top 5 pharmas. It was along those lines.
From 49 min 50 seconds of the podcast if anyone is interested.
Stop losses is the worst thing you can do in the AIM market. The mms will manoeuvre the sp to that level even if it’s for a split second. I did it once and it was the worst decision.
Your decision but I would suggest have a bit of patience. End of June I see new highs given the potential news flow.
Would have been disgusted if he did. Glad to see the BoD purchase some shares.
I really dislike them both. More so Fran.
They have a lot of making up to do!
I assume the institutions won’t be flipping them straight away. Be extremely surprised.
Inevitable, not happy how this company has handled itself but it was needed.
H2 just around corner and it’s go time. You jumping in now Chancers?
Got some more at 13.98 pence, not a huge amount as I have little cash but June is going to be a good month I feel.
If/ when the contracts are signed with the big pharmas at £6-7 million a go, the sp will increase on each of those pieces of news. I would say Significantly given the small market cap but I do not want to be seen as a ramper.
This is by far my best share holding.
My friend let’s see where the sp is in a week. This is an investment not a trade.
Will be worth it, I have very high hopes for this company.
I have an average of 9.5, my last top up was poorly timed at 16.20 pence but hey ho. Within a week the sp will be past that level.
I think they are getting worried. Makes me laugh how they stalk this BB.
Sad sad people
I would not trust a word out of his mouth. Complete con artist. He wants people to sell to get a cheaper entry. Unfortunately for him we are dealing with a completely different breed of company now. Covid-19 will be here with us until a vaccine,
40-50 pence by year end.
I politely disagree. We are still at the start of this epidemic which will be with us for the forceable future probably forever.
There will be be a need of constant checks moving forward throughout the world. We have a test that works and is now getting traction. Many companies with ‘new’ tests as you mentioned that have yet to be validated approved are behind the curve.
Also we are not a one product company. We have been established for many years with an array of different products now coming to the market.
Let’s see what the sp is in a months time.
Still confused. The RNS states that fundraising has now been completed and they have raised £12 million. So I assume the opportunity for shares at 11 pence has gone?
Never use stop losses. I got completely done over and learnt the hard way on Avacta. Sold my shares significantly lower than my stop loss and then it went on to bounce considerably.
MMS can see all stop losses so they drop the bid to hoover them up.
If you have a good company, stay and hold. Open Orphan is now entering another league. An amazing company.